SpeeDx

OverviewSuggest Edit

SpeeDx is a provider of innovative multiplex qPCR and isothermal amplification solutions for clinical diagnostics. The Company's flagship test is detecting the Mycoplasma genitalium infection, and genetic markers linked to macrolide antibiotic resistance. Its portfolio also includes tests for detection of gonorrhea infection and markers linked to susceptibility to ciprofloxacin.

TypePrivate
Founded2009
HQEveleigh, AU
Websiteplexpcr.com

Latest Updates

Employees (est.) (Mar 2020)47

Key People/Management at SpeeDx

Colin Denver

Colin Denver

CEO
Elisa Mokany

Elisa Mokany

Chief Technology Officer
Bhavin Raval

Bhavin Raval

CFO
Show more

SpeeDx Office Locations

SpeeDx has offices in Eveleigh, Austin and London
Eveleigh, AU (HQ)
145/4 Cornwallis St
London, GB
Kemp House, 152 - 160 City Rd, Old Street
Austin, US
UT Penick-Allison Tennis Center, 1601 Trinity St Building B
Show all (3)

SpeeDx Financials and Metrics

Summary Metrics

Founding Date

2009

SpeeDx total Funding

$30 m

SpeeDx latest funding size

$15 m

Time since last funding

2 months ago

SpeeDx investors

SpeeDx's latest funding round in February 2020 was reported to be $15 m. In total, SpeeDx has raised $30 m
Show all financial metrics

SpeeDx Online and Social Media Presence

Embed Graph

SpeeDx News and Updates

SpeeDx Blogs

SpeeDx Raise Additional $15 Million in Series B Funding

SpeeDx today announced it has raised $15 million in additional series B equity investment from U.S.-based Northpond Ventures. This investment ... The post SpeeDx Raise Additional $15 Million in Series B Funding appeared first on SpeeDx.

SpeeDx and LabCorp Working Together

SpeeDx and LabCorp are working together to develop and introduce new tests with the promise to help improve patient care, ... The post SpeeDx and LabCorp Working Together appeared first on SpeeDx.

Melbourne Sexual Health Continue Success with Resistance Guided Therapy

Mycoplasma genitalium (Mgen) infections treated using resistance guided therapy led to high cure rates and low levels of de novo ... The post Melbourne Sexual Health Continue Success with Resistance Guided Therapy appeared first on SpeeDx.

FIND Collaborate with SpeeDx and QuantuMDx

The Foundation for Innovative New Diagnostics (FIND) are supporting a collaboration with SpeeDx and QuantuMDx to assess the feasibility of ... The post FIND Collaborate with SpeeDx and QuantuMDx appeared first on SpeeDx.

TGA Clears ResistancePlus® MG FleXible for Sale in Australia

The Therapeutic Goods Administration (TGA) have cleared ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, and it is now available ... The post TGA Clears <em><b>Resistance</b>Plus</em><sup>®</sup> MG FleXible for Sale in Australia appeared first on Sp…

SpeeDx Receives CE-IVD Clearance for ResistancePlus® MG FleXible

ResistancePlus® MG FleXible for the Cepheid GeneXpert® System is now CE-IVD and available for sale in Europe. The test detects ... The post SpeeDx Receives CE-IVD Clearance for <em><b>Resistance</b>Plus</em><sup>®</sup> MG FleXible appeared first on SpeeDx.
Show more

SpeeDx Frequently Asked Questions

  • When was SpeeDx founded?

    SpeeDx was founded in 2009.

  • Who are SpeeDx key executives?

    SpeeDx's key executives are Colin Denver, Elisa Mokany and Bhavin Raval.

  • How many employees does SpeeDx have?

    SpeeDx has 47 employees.

  • Who are SpeeDx competitors?

    Competitors of SpeeDx include Cleveland HeartLab, TwistDx and Biosystems International.

  • Where is SpeeDx headquarters?

    SpeeDx headquarters is located at 145/4 Cornwallis St, Eveleigh.

  • Where are SpeeDx offices?

    SpeeDx has offices in Eveleigh, Austin and London.

  • How many offices does SpeeDx have?

    SpeeDx has 3 offices.